F
N+ Score49
Joint & BoneServing: 4 Capsule(s)Type: Other Combinations

TRMA by Thera-Zyme is an 'Other Combinations' supplement in the Joint & Bone category, containing three ingredients. It provides Calcium (72mg), Kelp (100mg), and a Proprietary Plant Enzyme Blend (593mg). This product received an N+ Score of 49, earning an 'F' grade, indicating a below-average quality tier. While Kelp is present at a clinically studied dosage of 100mg, Calcium is underdosed compared to typical recommendations for bone health. The inclusion of a proprietary blend reduces full transparency regarding individual enzyme dosages. This supplement may be considered by those seeking a combination product with some clinically dosed components, though the overall formulation suggests room for improvement in ingredient levels.

About This Product

TRMA by Thera-Zyme is a joint & bone supplement containing 3 active ingredients. It has earned an N+ Score of 49/100 (Grade F).

Notable clinical-dose ingredients include Kelp.

N+ Score Breakdown

Ingredient Adequacy25/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity72/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • −Several ingredients below clinically effective doses
  • −Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Calcium72.000 mgUnder
Kelp100.000 mgAdequate
Proprietary Plant Enzyme Blend593.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.